$INMB 4 SEC Filings

Filed On	Filing
23 Sep 2026	Form 4: Clark Ronnie Duane, Director Granted 100,000 Stock Options
17 Sep 2026	Form 4: Sapirstein James, Director Granted 100,000 Stock Options
07 Jul 2026	Form 4: Lowdell Mark William, Chief Scientific Officer Received 7,211 shares by exercise or conversion ($10.1K) · Exercised 7,211 Common Stock Purchase Warrant ($901)
07 Jul 2026	Form 4: Moss David J, Director Received 9,014 shares by exercise or conversion ($12.6K) · Exercised 9,014 Common Stock Purchase Warrant ($1.13K)
07 Jul 2026	Form 4: Juda Scott, Director Received 14,801 shares by exercise or conversion ($20.7K) · Exercised 14,801 Common Stock Purchase Warrant ($1.85K)
02 Dec 2025	Form 4: Moss David J, Director Granted 750,000 Option (right to buy)
02 Dec 2025	Form 4: Lowdell Mark William, Chief Scientific Officer Granted 600,000 Option (right to buy)
02 Dec 2025	Form 4: Ellspermann Cory Randall, CFO Granted 300,000 Option (right to buy)
02 Dec 2025	Form 4: Schroeder Timothy j, Director Granted 150,000 Option (right to buy)
02 Dec 2025	Form 4: Juda Scott, Director Granted 150,000 Option (right to buy)
02 Dec 2025	Form 4: Ganjei James Kelly, Director Granted 150,000 Option (right to buy)
02 Dec 2025	Form 4: Allen Marcia, Director Granted 150,000 Option (right to buy)
18 Nov 2025	Form 4: Schroeder Timothy j, Director Disposed of 366,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 366,000 Stock Option (right to buy)
18 Nov 2025	Form 4: Lowdell Mark William, Chief Scientific Officer Disposed of 924,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 924,000 Stock Option (right to buy)
18 Nov 2025	Form 4: Moss David J, Director Disposed of 1,478,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 1,478,000 Stock Option (right to buy)
18 Nov 2025	Form 4: Juda Scott, Director Disposed of 366,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 366,000 Stock Option (right to buy)
18 Nov 2025	Form 4: Ganjei James Kelly, Director Disposed of 366,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 366,000 Stock Option (right to buy)
18 Nov 2025	Form 4: Ellspermann Cory Randall, Interim CFO Disposed of 245,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 245,000 Stock Option (right to buy)
18 Nov 2025	Form 4: Allen Marcia, Director Disposed of 258,000 Stock Option (right to buy) (Disposition to Issuer) · Granted 258,000 Stock Option (right to buy)
09 Dec 2024	Form 4: Moss David J, Chief Financial Officer Granted 223,000 Option (right to buy)

Comments